CI_with has_Ingredient has_MoA has_PE may_treat drug associated with AE in adult drug associated with AE in senior used to treat disease Drug Hypersensitivity [Disease/Finding] Lymphoma, B-Cell [Disease/Finding] rituximab [Chemical/Ingredient] Increased Cellular Death [PE] Antibody-Receptor Interactions [MoA] R [Preparations] RITUXIMAB http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563#nlm34084-4 121191 <VANDF_Record>50.6^3496^</VANDF_Record><VA_File>50.6</VA_File><VA_IEN>3496</VA_IEN> rituximab N0000148560 Active Ingredient <VANDF_Record>50.416^3772^</VANDF_Record><VA_File>50.416</VA_File><VA_IEN>3772</VA_IEN> 4021104 4F4X42SYQ6 RITUXIMAB C0393022 C19592 non-Hodgkin lymphoma chronic lymphocytic leukemia Wegener's granulomatosis rheumatoid arthritis dyspnea AE nasopharyngitis AE upper respiratory tract infection AE fever AE infection AE pruritus AE asthenia AE arthralgia AE chills AE hypertension AE bronchitis AE urinary tract infection AE hypotension AE nausea AE vomiting AE lymphopenia AE neutropenia AE herpes viral infection AE